Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: POZEN
• Treatments: Esomeprazole; Naproxen

Criteria

Inclusion Criteria:

• Healthy male or non-pregnant female subjects between 18-55 years of age as well as other standard inclusion criteria for a study of this nature

Exclusion Criteria:

• Standard exclusion criteria for a study of this nature